Most commonly seen in young men (i.e., ages 20-40 years) of southeast Mediterranean origin and of Middle and Far East origin.[1]Mills JL, Porter JM. Buerger's disease (thromboangiitis obliterans). Ann Vasc Surg. 1991 Nov;5(6):570-2.
http://www.ncbi.nlm.nih.gov/pubmed/1772769?tool=bestpractice.com
In one study, the median age of onset was 36 years (interquartile range 29 to 44 years).[2]Le Joncour A, Soudet S, Dupont A, et al. Long-term outcome and prognostic factors of complications in thromboangiitis obliterans (Buerger's disease): a multicenter study of 224 patients. J Am Heart Assoc. 2018 Dec 4;7(23):e010677.
https://www.doi.org/10.1161/JAHA.118.010677
http://www.ncbi.nlm.nih.gov/pubmed/30571594?tool=bestpractice.com
The reported prevalence of Buerger disease ranges from 0.5% to 5.6% in Western European countries, 45% to 63% in India, and 16% to 66% in Korea and Japan. It has a higher incidence in the Ashkenazi Jewish population.[3]Arkkila PE. Thromboangiitis obliterans (Buerger's disease). Orphanet J Rare Dis. 2006 Apr 27;1:14.
https://www.doi.org/10.1186/1750-1172-1-14
http://www.ncbi.nlm.nih.gov/pubmed/16722538?tool=bestpractice.com
A decrease in the prevalence rate of diagnosis of Buerger disease was observed in the US between 1947 and 1986 (104 per 100,000 cases in 1947 to 13 per 100,000 cases in 1986).[4]Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn. 1989 Mar;39(3):153-8.
http://www.ncbi.nlm.nih.gov/pubmed/2662703?tool=bestpractice.com
The decline in morbidity may be associated with better health education, improved awareness of disease etiology, improved imaging modalities, and effectiveness of antibiotics.
Although Buerger disease is more commonly seen in men, approximately 23% of patients diagnosed with Buerger disease are women.[2]Le Joncour A, Soudet S, Dupont A, et al. Long-term outcome and prognostic factors of complications in thromboangiitis obliterans (Buerger's disease): a multicenter study of 224 patients. J Am Heart Assoc. 2018 Dec 4;7(23):e010677.
https://www.doi.org/10.1161/JAHA.118.010677
http://www.ncbi.nlm.nih.gov/pubmed/30571594?tool=bestpractice.com
[5]Olin JW, Young JR, Graor RA, et al. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation. 1990 Nov;82(5 suppl):IV3-8.
http://www.ncbi.nlm.nih.gov/pubmed/2225420?tool=bestpractice.com
[6]Zheng JF, Chen YM, Chen DY, et al. The incidence and prevalence of thromboangiitis obliterans in Taiwan: a nationwide, population-based analysis of data collected from 2002 to 2011. Clinics (Sao Paulo). 2016 Jul;71(7):399-403.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946527/?report=classic
http://www.ncbi.nlm.nih.gov/pubmed/27464297?tool=bestpractice.com
The increased incidence in women may be associated with an increase in smoking.[7]Yorukoglu Y, Ilgit E, Zengin M, et al. Thromboangiitis obliterans (Buerger's disease) in women (a reevaluation). Angiology. 1993 Jul;44(7):527-32.
http://www.ncbi.nlm.nih.gov/pubmed/8328680?tool=bestpractice.com